Stocks in Action: Fresenius, Essilor/Luxottica, Voestalpine, Nemetschek, and Siemens Energy.
Reading Time: 5 minutes
Stock 1.) Fresenius - Healthcare Group Back on Growth Path Thanks to Focus on Core Business, Barclays Confirms Outperform Rating and Raises Price Target to €58 (Upside Potential: 23%)! One of the most important buy ratings comes on Monday from Barclays for Fresenius. The healthcare group has managed to return to a growth path in recent years thanks to cost-cutting measures and the sale of non-core areas. CEO Michael Sen is trimming Fresenius for profitability, particularly in its hospital subsidiary HELIOS, and the highly profitable subsidiary...
Read this article now with a free account.
Your benefits:
- Every month, you can read 5 articles from the premium section for free.
- Monthly 2 trial issues of the Trader newspaper for free.
- Create a personal watchlist with an overview of news about your stock.
